Study to Examine Effect of Recombinant Luteinizing Hormone (r-Lh) and Recombinant Human Chorionic Gonadotropin (r-hCG) for Ovarian Stimulation in Assisted Reproduction Techniques (ART)

Inclusion Criteria: * Women who plan to undergo IVF or ICSI treatment * Woman's age \> 18 years but ≤ 35 years * Regular menstrual cycle (25-34 days) * BMI 18 to 30 inclusive * Signed patient information and informed consent forms Exclusion Criteria: * PCOS * More than 2 prior IVF/ICSI attempts * Diabetes mellitus, epilepsy, lever-, kidney-, heart- and metabolism disorders, according to the Investigator's assessment.